The Reality and Recommendations for The Reimbursement Policy of Rare Diseases in the National Health Insurance Program
碩士 === 國立交通大學 === 科技法律研究所 === 105 === Whether drugs are recognized as a rare disease medication, and whether health insurances reimburses the drugs, often depend on the mechanisms of scientific and medical expert review meetings. The policymaking for rare diseases is often based on insufficient evi...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2017
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/dtyx89 |